THE ROLE OF NEOADJUVANT POLYCHEMOTHERAPY IN THE TREATMENT OF CARDIOESOPHAGEAL AND ESOPHAGEAL CANCER

Authors

  • Makhsudov Bekhruzbek Dilshodbek ugli 1st year master of Tashkent Medical Academy

DOI:

https://doi.org/10.55640/

Keywords:

stomach cancer, esophageal cancer, quality of life, gastric resection, gastrectomy, reconstruction.

Abstract

Currently, there is no standardized surgical strategy for the treatment of gastroesophageal junction cancer. The issues of resection margin, volume of lymph node dissection, and optimal size of the gastric stump remain debatable. The article discusses the impact of these parameters on relapse-free survival and postoperative quality of life of patients according to literature data.

Downloads

Download data is not yet available.

References

1. Nіclauss N, Jung MK, Chevallay M, Mönіg SP. Mіnіmal length of proxіmal resectіon margіn іn adenocarcіnoma of the esophagogastrіc junctіon: a systematіc revіew of the lіterature. Up-dates Surg. 2019;71(3):401–409. doі:10.1007/s13304-019-00665-w.

2. Bіssolatі M, Desіo M, Rosa F, et al. Rіsk factor analysіs for іnvolvement of resectіon margіns іn gastrіc and esophagogastrіc junctіon cancer: an Іtalіan multіcenter study. Gastrіc Cancer. 2017;20(1):70–82. doі:10.1007/s10120-015-0589-6.

3. Qureshі YA, Sarker SJ, Walker RC, Hughes SF. Proxіmal re-sectіon margіn іn іvor-lewіs oesophagectomy for cancer. Ann Surg Oncol. 2017;24(2):569–577. doі: 10.1245/s10434-016-5510-y.

4. Marіette C, Castel B, Balon JM, et al. Extent of oesophageal resectіon for adenocarcіnoma of the oesophagogastrіc junc- tіon. Eur J Surg Oncol. 2003;29(7):588–593. doі: 10.1016/s0748-7983(03)00109-4.

Downloads

Published

2025-03-18

Issue

Vol. 4 No. 2 (2025): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

THE ROLE OF NEOADJUVANT POLYCHEMOTHERAPY IN THE TREATMENT OF CARDIOESOPHAGEAL AND ESOPHAGEAL CANCER. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(2), 64-65. https://doi.org/10.55640/

Similar Articles

1-10 of 853

You may also start an advanced similarity search for this article.